Clinical trial
Subclinical Atherosclerosis in HIV-infected Patients
NCT00455793 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00455793 |
|---|---|
| Title | Subclinical Atherosclerosis in HIV-infected Patients |
| Official title | Subclinical Atherosclerosis in HIV-infected Patients |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections, Coronary Atherosclerosis |
| Enrollment | 263 |
| Start date | Jun 1, 2006 |
| Primary completion | Feb 1, 2013 |
| Completion | Feb 1, 2013 |
| First posted | Apr 4, 2007 |
| Last update posted | Dec 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: